IRCT20240804062647N1招募中Unknown
Bioequivalence study of famotidine 40 mg tablets produced by Actoverco pharmaceutical company with the reference drug Pepcid 40 mg manufactured by Merck company
?Actoverco Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-30)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to Famotidine
研究者
相似试验
招募中
Unknown
Bioequivalence study of famotidine 40 mg tabletIRCT20230222057495N12Ramopharmin Pharmaceutical Company24
已完成
不适用
Bioequivalance study of Famotidine 40 mgIRCT20200513047423N5Fatak chemie pars Pharmacy24
尚未招募
不适用
Bioequivalance study of Famotidine 40 mgSubject: Bioequivalence of Famotidine 40 mg Tablet and Comparison of Pharmacokinetic Parameters with Ratiopham Reference Tablet.IRCT20200513047423N9Iran Daru Pharmaceutical Company24
招募中
Unknown
Bioequivalence study of Famotidine 40 mg tabletIRCT20210519051345N32Tabriz University of Medical Sciences24
尚未招募
不适用
Bioequivalence study of Famotidine 40 mgIRCT20200623047902N14Sanamed pharma company24